Cost-Utility Analysis of Primary Prophylaxis Versus Secondary Prophylaxis With Granulocyte Colony-Stimulating Factor in Elderly Patients With Diffuse Aggressive Lymphoma Receiving Curative-Intent Chemotherapy

The 2006 American Society of Clinical Oncology (ASCO) guideline recommended primary prophylaxis (PP) with granulocyte colony-stimulating factor (G-CSF) instead of secondary prophylaxis (SP) for elderly patients with diffuse aggressive lymphoma receiving chemotherapy. We examined the cost-effectivene...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology 2012-04, Vol.30 (10), p.1064-1071
Hauptverfasser:	CHAN, Kelvin K. W, SIU, Eric, KRAHN, Murray D, IMRIE, Kevin, ALIBHAI, Shabbir M. H
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Biological and medical sciences Chemotherapy Cost-Benefit Analysis Data processing Drug Administration Schedule Economics Female Geriatrics Granulocyte colony-stimulating factor Granulocyte Colony-Stimulating Factor - administration & dosage Granulocyte Colony-Stimulating Factor - economics Granulocyte Colony-Stimulating Factor - therapeutic use Hematologic and hematopoietic diseases Humans Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Lymphoma Lymphoma, Non-Hodgkin - drug therapy Lymphoma, Non-Hodgkin - economics Male Markov Chains Medical sciences Middle Aged Neutropenia Oncology Ontario Primary Prevention - economics Primary Prevention - methods Prophylaxis Quality-Adjusted Life Years Risk assessment Secondary Prevention - economics Secondary Prevention - methods Substance P Treatment Outcome Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!